146 related articles for article (PubMed ID: 35332289)
21. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
[TBL] [Abstract][Full Text] [Related]
22. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
Mikhail M; Stewart S; Seow F; Hogg R; Lois N
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188
[TBL] [Abstract][Full Text] [Related]
23. Mean macular intercapillary area in eyes with diabetic macular oedema after anti-vascular endothelial growth factor therapy and its association with treatment response.
Sorour OA; Elsheikh M; Chen S; Elnahry AG; Baumal CR; Pramil V; Abdelhalim TI; Nassar E; Moult EM; Witkin AJ; Duker JS; Waheed NK
Clin Exp Ophthalmol; 2021 Sep; 49(7):714-723. PubMed ID: 34189816
[TBL] [Abstract][Full Text] [Related]
24. Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography.
Silva PS; Dela Cruz AJ; Ledesma MG; van Hemert J; Radwan A; Cavallerano JD; Aiello LM; Sun JK; Aiello LP
Ophthalmology; 2015 Dec; 122(12):2465-72. PubMed ID: 26350546
[TBL] [Abstract][Full Text] [Related]
25. Microaneurysm density in residual oedema after anti-vascular endothelial growth factor therapy for diabetic macular oedema.
Yamada Y; Takamura Y; Morioka M; Gozawa M; Matsumura T; Inatani M
Acta Ophthalmol; 2021 Sep; 99(6):e876-e883. PubMed ID: 33326191
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
Spooner K; Fraser-Bell S; Hong T; Chang A
Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
[TBL] [Abstract][Full Text] [Related]
27. Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study.
Kwon S; Wykoff CC; Brown DM; van Hemert J; Fan W; Sadda SR
Br J Ophthalmol; 2018 Aug; 102(8):1066-1071. PubMed ID: 29699979
[TBL] [Abstract][Full Text] [Related]
28. Ranibizumab treatment improves diabetic macular oedema without influencing retinal oximetry parameters.
Takasago Y; Fujita T; Nakano Y; Osaka R; Miyake M; Muraoka Y; Tsujikawa A
Acta Ophthalmol; 2019 Dec; 97(8):e1048-e1053. PubMed ID: 31127694
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
Ebneter A; Wolf S; Zinkernagel MS
Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
[TBL] [Abstract][Full Text] [Related]
30. Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data.
Sadda SR; Campbell J; Dugel PU; Holekamp NM; Kiss S; Loewenstein A; Augustin AJ; Shih V; Xu X; Wykoff CC; Whitcup SM
Eye (Lond); 2020 Mar; 34(3):480-490. PubMed ID: 31320738
[TBL] [Abstract][Full Text] [Related]
31. Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema.
Wessel MM; Nair N; Aaker GD; Ehrlich JR; D'Amico DJ; Kiss S
Br J Ophthalmol; 2012 May; 96(5):694-8. PubMed ID: 22423055
[TBL] [Abstract][Full Text] [Related]
32. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study.
Szeto SK; Hui VWK; Tang FY; Yang D; Sun ZH; Mohamed S; Chan CKM; Lai TYY; Cheung C
Br J Ophthalmol; 2023 Apr; 107(4):525-533. PubMed ID: 34750100
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
Ceylan A; Dogan ME; Demircan A; Akar Y
Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
[TBL] [Abstract][Full Text] [Related]
34. Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography.
Toto L; D'Aloisio R; Libertini D; D'Onofrio G; De Nicola C; Mastropasqua R; Chiarelli AM
Ophthalmic Res; 2023; 66(1):8-13. PubMed ID: 35313317
[TBL] [Abstract][Full Text] [Related]
35. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis).
Terai N; Haustein M; Siegel A; Stodtmeister R; Pillunat LE; Sandner D
Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978
[TBL] [Abstract][Full Text] [Related]
36. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment.
Leicht SF; Kernt M; Neubauer A; Wolf A; Oliveira CM; Ulbig M; Haritoglou C
Ophthalmologica; 2014; 231(4):198-203. PubMed ID: 24662930
[TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature.
Sacconi R; Corbelli E; Carnevali A; Mercuri S; Rabiolo A; Querques L; Marchini G; Bandello F; Querques G
Br J Ophthalmol; 2018 Dec; 102(12):1684-1690. PubMed ID: 29463502
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
[TBL] [Abstract][Full Text] [Related]
39. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
[TBL] [Abstract][Full Text] [Related]
40. One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.
Borrelli E; Parravano M; Querques L; Sacconi R; Giorno P; De Geronimo D; Bandello F; Querques G
Acta Diabetol; 2020 May; 57(5):543-548. PubMed ID: 31749052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
